It was reported to boston scientific corporation that a spaceoar vue device implanted during a spaceoar vue placement procedure on (b)(6) 2023.Prophylactic antibiotics were administered prior to injection.The procedure was performed under local anesthesia, lidocaine and pentrox anesthetic.It was noted that the successful placement procedure was confirmed under ultrasound.No patient complications were reported, during the procedure.On (b)(6) 2023, prior to the placement procedure, the patient experienced non serious urinary urgency and renal and urinary disorder, nocturia.No medication was given to the patient this time.On december 11, 2023, the patient started his radiation treatment delivered via lineal accelerator (linac).Later on, december 15, 2023, 32 days after the placement procedure, the patient experienced a non-serious renal and urinary disorders and urinary urgency.The patient received medication.These events have been reported ongoing at the time of this report.The patient current condition is unknown.Boston scientific was unable to obtain additional information despite good faith efforts.
|